A personalised vaccine for the aggressive and fatal brain cancer glioblastoma has shown encouraging signs of efficacy in its first human trial. The vaccine – developed by researchers at the ...

He explained in a blog post that he’s hoping to “raise money to pay for a vaccine that is the most promising treatment for Glioblastoma in 30 years, and can potentially add years to my life.” On the ...

Finding a drug to advance treatment of glioblastoma (GBM ... latter will test its Keytruda in combination with Agenus' cancer vaccine Prophage. Another competitor is Regeneron which is ...

Death Records examined data from the Centers for Disease Control and Prevention to understand and explain the evolution in ...

INOVIO (NASDAQ: INO) revealed its strategic milestones for 2025, positioning the company for significant advancements as it ...

A new therapy for the most aggressive type of brain cancer can extend patients' survival while cutting the length of ...

Glioblastoma often kills within months. A new targeted radiation therapy may help patients live longer. When you purchase through links on our site, we may earn an affiliate commission. Here’s ...

Dec. 9, 2024 — Researchers used lab-grown organoids created from tumors of individuals with glioblastoma (GBM) to accurately model a patient's response to CAR T cell therapy in real time.

In two new studies, scientists report that the ... Dec. 10, 2024 — A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody ...

Frontotemporal dementia (FTD) is a rare and progressive form of dementia that primarily affects people between the ages of 40 ...